The B20 Health Conference
18 May 2017
Following our “G20 Global Health Innovation” roundtable discussions in Berlin on 28th April, we were honoured to be part of the B20 Health Conference on 18th May 2017 where our Executive Chairman Alan Donnelly highlighted the importance of a mutli-stakeholder cooperation between politicians, the private sector and public private partnerships as well as NGO’s in order to address the interrelated challenges of Antimicrobial Resistance (AMR), pandemic preparedness/ response and Poverty Related Neglected Diseases (PRNDs).
He joined Merck, CEPI and FIND in order to discuss ways to eliminate Neglected Tropical Diseases (NTDs) by 2020. Sovereign Strategy welcomed the attendance of Dr. Hatchett (CEPI), Dr. Stormy-Annika Mildner (B20), Dr. Harald Nusser (Novartis) and many other high-level attendees, at both our G20 Global Health Innovation event and the B20 Health Conference. We are grateful to the B20 and its Health Initiative for this inspiring conference and the convergence, in several areas, between our Initiative and the B20.
We are appreciative of the impact that our “G20 Global Health Innovation” roundtable discussions and our Call to Action had on the final G20 Health Ministers Declaration. We welcome the good result that health will feature prominently in the high-level recommendations for an upgraded G20 partnership with Africa and specifically with countries that are part of the G20 Compact with Africa.